"Origination of Macrocyclic Formazan with Macrocyclic Sulfazan and Triazan as Innovated Compounds and Compared Their efficiency Against Breast Cancer"

Abstract

How to cite this article: Nagham Mahmood A. Origination of Macrocyclic Formazan with Macrocyclic Sulfazan and Triazan as Innovated Compounds and Compared Their efficiency Against Breast Cancer. ABSTRACT Macrocyclic Sulfazan and Macrocyclic Formazan were created and developed globally for the first time by researcher Dr. Nagham Aljamali in April 2021, while same researcher created and innovated Sulfazan compounds as the first time in 2019., Therefore, these compounds considered one of the developed and modern compounds which have a lack of references or scarcity of books and researches. Therefore, the researcher, Dr. Nagham prepared and created a chain of these innovated compounds and studied by numerous applications, containing biological, pharmaceutical studies, also as antifungal, antibacterial, anticancer agents, and here in this research, also cyclic sulfazan and cyclic formazan were studied a several applications. A numeral of practical spectroscopic studies has been used to exhibit their chemical structures which provided strong evidence of their chemical structures through various technical devices like (FT IR-Spectra, 1H.NMR-Spectra, Mass-Spectra)., Melting points, other studies represented by evolution them as bio-compounds by scanning them as anticancer compounds.